{"DataElement":{"publicId":"4865757","version":"1","preferredName":"Laboratory Procedure Urine N-Telopeptide Creatinine Ratio Outcome Value","preferredDefinition":"A nonenumerated data element to report the ratio of N-telopeptide concentration compared to the amount of creatinine in the urine.","longName":"LbPrdUrnNTXCr89RtoVal","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4865753","version":"1","preferredName":"Laboratory Procedure Urine N-Telopeptide Creatinine Ratio Outcome","preferredDefinition":"Information related to the results of a procedure that measures N-telopeptide against creatinine within a urine sample.","longName":"LabPdrUrnNTXCr89RtoOut","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4865756","version":"1","preferredName":"Urine N-Telopeptide Creatinine Ratio Outcome","preferredDefinition":"The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.:This polypeptide is comprised of the amino terminal portions of fibrillar collagen, which are not part of the triple helical structure. Bone resorption of type I collagen by osteoclasts results in the release of this peptide. Thus, this polypeptide is utilized as a biomarker for bone loss.:The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.:Quotient of quantities of the same kind for different components within the same system.:The result of an action.","longName":"4865756v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urine","conceptCode":"C13283","definition":"The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"N-Telopeptide","conceptCode":"C68563","definition":"This polypeptide is comprised of the amino terminal portions of fibrillar collagen, which are not part of the triple helical structure. Bone resorption of type I collagen by osteoclasts results in the release of this peptide. Thus, this polypeptide is utilized as a biomarker for bone loss.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Creatinine","conceptCode":"C399","definition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"185BB1AC-44CD-12DD-E050-BB89AD431BE1","latestVersionIndicator":"Yes","beginDate":"2015-06-12","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-06-12","modifiedBy":"ONEDATA","dateModified":"2015-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"185B5388-0C01-9300-E050-BB89AD4333DF","latestVersionIndicator":"Yes","beginDate":"2015-06-12","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-06-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4865755","version":"1","preferredName":"Urine N-Telopeptide Creatinine Ratio Value","preferredDefinition":"A nonenumerated value domain to report the ratio of N-telopeptide concentration compared to the amount of creatinine in the urine.","longName":"UrnNTXCr89Val","context":"COG","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4865754","version":"1","preferredName":"Urine N-Telopeptide Creatinine Ratio Value","preferredDefinition":"The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.:This polypeptide is comprised of the amino terminal portions of fibrillar collagen, which are not part of the triple helical structure. Bone resorption of type I collagen by osteoclasts results in the release of this peptide. Thus, this polypeptide is utilized as a biomarker for bone loss.:The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.:Quotient of quantities of the same kind for different components within the same system.:A numerical quantity measured or assigned or computed.","longName":"4865754v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urine","conceptCode":"C13283","definition":"The fluid that is excreted by the kidneys.  It is stored in the bladder and discharged through the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"N-Telopeptide","conceptCode":"C68563","definition":"This polypeptide is comprised of the amino terminal portions of fibrillar collagen, which are not part of the triple helical structure. Bone resorption of type I collagen by osteoclasts results in the release of this peptide. Thus, this polypeptide is utilized as a biomarker for bone loss.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Creatinine","conceptCode":"C399","definition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"185BB1AC-449D-12DD-E050-BB89AD431BE1","latestVersionIndicator":"Yes","beginDate":"2015-06-12","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-06-12","modifiedBy":"ONEDATA","dateModified":"2015-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"185BB1AC-44AE-12DD-E050-BB89AD431BE1","latestVersionIndicator":"Yes","beginDate":"2015-06-12","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-06-12","modifiedBy":"MIRANDAA","dateModified":"2016-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Urine n-telopeptide to creati","type":"Preferred Question Text","description":"Urine n-telopeptide to creatinine ratio","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"185BB1AC-44E4-12DD-E050-BB89AD431BE1","latestVersionIndicator":"Yes","beginDate":"2015-06-12","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-06-12","modifiedBy":"MIRANDAA","dateModified":"2015-06-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}